PTGER4 and neoplasm: Treatment of TI 4662 MD7 tumor cells (Supplemental Figure 6, A and B) in vitro with the EP4 antagonist ONO-AE3-208 (αEP4) resulted in a dose-dependent inhibition of EP4 signaling, as measured by cAMP production (Figure 4A).